![]() The largest cause of action against the drug is that it causes males to develop gynecomastia. The Food and Drug Administration did not approve this use as safe and effective.ĭeceptive marking actions are not the only claims against Risperdal. The Department of Justice stated Risperdal and two other Johnson & Johnson drugs were promoted for dementia patients, when Risperdal was approved only to treat schizophrenia. In one of the largest health care fraud settlements in United States history, Johnson & Johnson was forced to pay more than $2 billion in penalties and settlements to state and government entities as a result of lawsuits relating to Risperdal and two other drugs, as well as civil and criminal complaints about their use. ![]() Risperdal has received a significant amount of attention dating back to 1994, when the drug first went on the market and Johnson & Johnson was accused of illegal marketing activities. Risperdal’s Litigation History and Current Lawsuits Due to the scientific and medical nature of the drug’s effects, experts in the field may strongly impact the verdict. Mostly comprised of individual suits rather than class actions, the verdicts may differ greatly, depending upon the evidence presented in each case. This past year, however, Risperdal has accounted for over a third of all mass tort lawsuits pending in the Philadelphia Complex Litigation Center. Risperdal has been the center of litigation for years due to allegations that the drug causes breast tissue growth in young males, a condition referred to as gynecomastia. There has been a huge spike in mass tort litigation due to the Johnson & Johnson medication, Risperdal, an anti-psychotic drug used to treat schizophrenia and other psychiatric disorders.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |